Price

Daily adjusted close · last point is delayed last sale · drag the brush to zoom

1D+0.6%
1W+2.5%
1M+4.7%
3M-5.6%
6M+22.3%
YTD+15.2%
1Y+29.0%
2Y+71.8%
Statusinvestigate
Researchprimary verified
Market cap$49.23B
Updated8/24/2026
Revenue (qtr)$2.31B
FCF (qtr)$654.0M
Capex (qtr)$70.0M
Net debt$2.09B

Summary

Research status: Primary-source verified through Rockwell Automation Q3 FY2026 results and current investor materials. Valuation basis: $437.08 close on 21 August 2026.

Rockwell is a genuine industrial-automation/Physical-AI diversifier rather than another semiconductor proxy. Q3 FY2026 organic sales grew 10%, adjusted EPS grew 22%, organic ARR grew 6%, and management updated FY2026 organic sales growth guidance to 7.5–9.5% with adjusted EPS of $13.00–13.30.

The strongest current business is Software & Control, while Lifecycle Services remains softer. Rockwell's installed Allen-Bradley/Logix base, distributor network and engineering/software integration create meaningful switching costs, especially in North American discrete automation.

At $437.08, however, the stock already discounts a meaningful recovery and trades more like a quality compounder than a cyclical industrial. PowerFund views ROK as a strategically useful Robotics/AI diversifier but wants either further earnings revisions or a better valuation before allocating meaningful capital.

Thesis

Investment case

Rockwell supplies control systems, software, drives and lifecycle services that automate factories and logistics. Physical AI may increase the value of its installed architecture as robotics, machine vision, autonomous material movement and data-driven control become more integrated.

> The PowerFund thesis is that Rockwell can compound through a cyclical recovery while its software/control installed base gains content from increasingly autonomous factories. The thesis only works from today's valuation if organic growth remains mid/high single digits and margin/ARR improvement persists beyond restructuring benefits.

Verified operating baseline — Q3 FY2026

  • Reported sales: +8% YoY.
  • Organic sales: +10% YoY.
  • Adjusted EPS: $3.49, +22% YoY.
  • Organic ARR: +6% YoY.
  • Software ARR: high-single-digit growth.
  • FY2026 organic sales growth guidance: 7.5–9.5%.
  • FY2026 adjusted EPS guidance: $13.00–13.30.

KPI ladder

KPIThesis-supportiveWarning
Organic growth>5–7%<3%
Software ARR>7–10%<5%
Enterprise margin>21–22%<20.5%
Lifecycle book-to-bill>1x<0.95 twice
FCF conversionstrong<80% of net income
S&C growth>10%<8%
RPOstable/rising>10% decline

PowerFund valuation scenarios

These are PowerFund estimates, not company guidance.

24 months

  • Bear (20%) — $320–360: industrial recovery fades, Lifecycle weakness persists and multiple compresses.
  • Base (55%) — $470–530: organic growth settles ~5–7%, margins remain >21% and EPS compounds high-single/low-double digits.
  • Bull (25%) — $620–700: automation cycle accelerates, software/control growth remains double-digit and operating leverage persists.

Probability-weighted midpoint is roughly $475–525/share.

60 months

  • Bear: $350–420.
  • Base: $650–850 if Rockwell compounds as a high-quality automation/software platform.
  • Bull: $1,000–1,250+ if Physical AI materially expands content per factory/warehouse.

Catalysts

  • FY2026 delivery near the high end of organic-growth/EPS guidance.
  • FY2027 guide showing mid-single-digit+ growth without needing a broad industrial boom.
  • Lifecycle book-to-bill recovering >1x.
  • Software & Control sustaining double-digit growth.
  • Automotive/life-science/process projects becoming named order growth.
  • Clearpath/Production Logistics scaling profitably.
  • Software ARR accelerating toward double digits.

Risks

  • Valuation: quality/recovery multiple is already high.
  • Industrial cyclicality: broad factory capex can weaken abruptly.
  • AI overlap: semiconductor/data-center verticals contribute to current strength.
  • Lifecycle softness: services/book-to-bill remain less robust.
  • Competition: Siemens, Schneider, ABB, Emerson and Honeywell have broader portfolios.
  • Margin quality: restructuring/Sensia changes can flatter comparisons.
  • Debt/goodwill: acquisition history requires capital-allocation discipline.
  • Distributor inventory: sell-in can diverge from end demand.

Invalidation

Warning — freeze additions

  • FY2026 organic growth below 7.5% or adjusted EPS below $13.00.
  • Enterprise margin below 20.5%.
  • Lifecycle book-to-bill <0.95 twice or <0.90 once.
  • Software ARR growth <5%.
  • RPO declines >10%.

Reduce

  • FY2027 guide implies <3% organic growth / <5% EPS growth.
  • Software & Control growth <8% while valuation remains premium.
  • FCF conversion weakens materially.
  • Distributor/end-demand data show sustained destocking.

Invalidate

> Invalidate if Rockwell's installed-base/software moat stops producing above-cycle growth and margin resilience—specifically, if organic growth settles near low single digits, ARR stalls and margins structurally weaken despite automation investment.

Competitive notes

Rockwell is strongest in North American discrete automation and integrated control/software.

  • Siemens: broader globally and stronger in engineering software.
  • Schneider: pairs automation with electrical distribution.
  • ABB: broader motion/robotics.
  • Emerson/Honeywell: stronger in process industries.

Rockwell's moat is installed control architecture, distributor reach, engineering familiarity and switching costs. Physical AI can raise content, but the company must prove it can monetize robotics/autonomy rather than merely benefit from a cyclical capex recovery.

Next diligence

  1. Track segment backlog/RPO beyond aggregate disclosures.
  2. Separate restructuring/Sensia margin effects from organic improvement.
  3. Monitor distributor sell-through and end-market orders.
  4. Identify named robotics/warehouse/automotive programs.
  5. Compare normalized EBIT/FCF valuation with Siemens, Schneider, ABB and Emerson.
  6. Define correction-readiness valuation zones.

Next full review: after Q4/FY2026 results and FY2027 guidance.